PKM and urinary bladder carcinoma: Given the importance of altered tumor metabolism in tumor development, and the stark contrast previously established in PKM2 expression in normal versus bladder cancer tumors, we wanted to determine if Tumor M2-PK present in urine could serve as a biomarker [19–22].